These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21450506)

  • 1. [Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma].
    Malkoun N; Fotso MJ; Cartier L; Forest F; Auberdiac P; Chargari C; Thorin J; Pacaut C; Peoc'h M; Nuti C; Schmitt T; Magné N
    Cancer Radiother; 2011 Jun; 15(3):202-7. PubMed ID: 21450506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
    Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
    Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma.
    Darlix A; Baumann C; Lorgis V; Ghiringhelli F; Blonski M; Chauffert B; Zouaoui S; Pinelli C; Rech F; Beauchesne P; Taillandier L
    Anticancer Res; 2013 Aug; 33(8):3467-74. PubMed ID: 23898121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of extended adjuvant temozolomide beyond six cycles for patients with glioblastoma.
    Hsieh SY; Chan DT; Kam MK; Loong HH; Tsang WK; Poon DM; Ng SC; Poon WS
    Hong Kong Med J; 2017 Dec; 23(6):594-8. PubMed ID: 28798282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
    Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis.
    Erpolat OP; Akmansu M; Goksel F; Bora H; Yaman E; Büyükberber S
    Tumori; 2009; 95(2):191-7. PubMed ID: 19579865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
    Brandes AA; Franceschi E; Tosoni A; Benevento F; Scopece L; Mazzocchi V; Bacci A; Agati R; Calbucci F; Ermani M
    Cancer; 2009 Aug; 115(15):3512-8. PubMed ID: 19514084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
    Clarke JL; Iwamoto FM; Sul J; Panageas K; Lassman AB; DeAngelis LM; Hormigo A; Nolan CP; Gavrilovic I; Karimi S; Abrey LE
    J Clin Oncol; 2009 Aug; 27(23):3861-7. PubMed ID: 19506159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.
    Skardelly M; Dangel E; Gohde J; Noell S; Behling F; Lepski G; Borchers C; Koch M; Schittenhelm J; Bisdas S; Naumann A; Paulsen F; Zips D; von Hehn U; Ritz R; Tatagiba MS; Tabatabai G
    Oncologist; 2017 May; 22(5):570-575. PubMed ID: 28360216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
    Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma.
    Muni R; Minniti G; Lanzetta G; Caporello P; Frati A; Enrici MM; Marchetti P; Enrici RM
    Tumori; 2010; 96(1):60-4. PubMed ID: 20437859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
    Kimple RJ; Grabowski S; Papez M; Collichio F; Ewend MG; Morris DE
    Am J Clin Oncol; 2010 Jun; 33(3):265-70. PubMed ID: 19823072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early postsurgical temozolomide treatment in newly diagnosed bad prognosis glioblastoma patients: Feasibility study].
    Chaskis E; Luce S; Goldman S; Sadeghi N; Melot C; De Witte O; Devriendt D; Lefranc F
    Bull Cancer; 2018; 105(7-8):664-670. PubMed ID: 29937336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
    Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
    Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative treatment of glioblastoma multiforme with radiation therapy plus concomitant and adjuvant temozolomide : A mono-institutional experience of 215 patients.
    Julka PK; Sharma DN; Mallick S; Gandhi AK; Joshi N; Rath GK
    J Cancer Res Ther; 2013; 9(3):381-6. PubMed ID: 24125970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.